Trial intelligence / Profile preview

BCG vaccination effects on bone marrow cells

NL-OMON43468Recruiting

Sponsor
Radboudumc
Start
Jan 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label, single-arm trial of bcg vaccine in Infectious disease, sponsored by Radboudumc. Primary endpoints: Cellular composition of bone marrow compartment by FACS and Ex-vivo cytokine release after stimulation. Started Jan 2017; status: recruiting.

02

Drugs

bcg vaccine
03

Conditions

Infectious disease

Beyond the preview

Go deeper on NL-OMON43468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call